What is Differin®? How does Differin&#174 work? How do I use Differin®?

Privacy Statement.

Galderma Laboratories, L.P.
Internet Privacy Policy

Galderma respects the privacy of every individual visiting our websites. Galderma's Privacy Policy, outlining the information Galderma collects and how Galderma uses such information is as follows:

Personally Identifiable Information
Galderma collects personally identifiable information (such as name, address, telephone/fax number and email address) only when voluntarily provided by a visitor to our websites. Galderma does not sell, rent or otherwise make available any personally identifiable information submitted by visitors to our website to any third parties. This information will not be used for any direct marketing or unsolicited follow-up unless we have previously informed you of this possible use and you have given us your express permission when submitting it. After obtaining your consent, Galderma may use this information for such purposes as:

  • Sending paper publications or other correspondence to you
  • Sending email press releases or notification to you
  • Delivering goods or prizes

Only authorized Galderma staff or our agents (who have agreed to keep information secure) have access to personally identifiable information.

Galderma does make use of non-personally identifiable statistical information collected from users (browser type, geographical location, age, gender) for optimization of its sites as part of its continual internal review process and in a general way to learn more about its clients. This information will not be disclosed to third parties by Galderma. This data will only be used for the stated purpose and will not be used for any unsolicited communication unless you give us permission.

Log Files
We use IP addresses to analyze trends, administer the site, track users' movements, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Cookies
Galderma does use tracking technology (known as 'cookies'), which deposits certain bits of information on your hard drive. Cookies allow us to track and target your interests to tailor our sites to suit your needs better.

Children
Children and young people under the age of 16 are requested to get permission from their parent or guardian before they submit personal data to Galderma websites.

Links
Links from this site may take you to other sites. Please be aware that we are not responsible for the privacy practices of such other sites. We advise you to check their privacy policies yourself before submitting any personally identifiable information.

Changes
By using this Web site, you signify your agreement to the terms and conditions of this Privacy Policy. If you do not agree to these terms and conditions, please do not disclose any personally identifiable information though this Web site. This policy may be modified from time to time, and changes will be communicated promptly on this page. Please contact us for more information on this policy.

Webmaster
Galderma Laboratories, L.P.
webmaster@galderma.com

Important Safety Information

Indication: DIFFERIN® GEL 0.3% and DIFFERIN® LOTION 0.1% are are prescription medication known as a retinoid and are indicated for the topical treatment of acne vulgaris in patients 12 years and older. Adverse Events: In controlled clinical studies, the most commonly reported (≥1%) adverse events in patients treated with DIFFERIN® GEL 0.3% were dry skin, skin discomfort, pruritus, desquamation, and sunburn. The most commonly reported (≥1%) adverse events in patients treated with DIFFERIN® LOTION 0.1% were erythema, scaling, dryness, and stinging/burning. Warnings/Precautions: The following apply to both DIFFERIN® GEL 0.3% and DIFFERIN® LOTION 0.1%. Patients should minimize exposure to sunlight, including sunlamps, while using DIFFERIN®. If exposure cannot be avoided, sunscreen products and protective apparel should be used. Weather extremes, such as wind or cold, may be irritating to patients undergoing treatment. Avoid contact with the eyes, lips, angles of the nose and mucous membranes. Do not use on cuts, abrasions, eczematous or sunburned skin. As with other retinoids, use of waxing should be avoided on skin treated with adapalene. Patients should use caution with use of DIFFERIN® in combination with products that are potentially irritating, have high concentrations of astringents or alcohol, or contain sulfur, resorcinol, or salicylic acid.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Home
Contact Us
Legal
Privacy
Prescribing Information

©2013 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Indication: DIFFERIN® GEL 0.3% and DIFFERIN® LOTION 0.1% are are prescription medication known as a retinoid and are indicated for the topical treatment of acne vulgaris in patients 12 years and older. Adverse Events: In controlled clinical studies, the most commonly reported (≥1%) adverse events in patients treated with DIFFERIN® GEL 0.3% were dry skin, skin discomfort, pruritus, desquamation, and sunburn. The most commonly reported (≥1%) adverse events in patients treated with DIFFERIN® LOTION 0.1% were erythema, scaling, dryness, and stinging/burning. Warnings/Precautions: The following apply to both DIFFERIN® GEL 0.3% and DIFFERIN® LOTION 0.1%. Patients should minimize exposure to sunlight, including sunlamps, while using DIFFERIN®. If exposure cannot be avoided, sunscreen products and protective apparel should be used. Weather extremes, such as wind or cold, may be irritating to patients undergoing treatment. Avoid contact with the eyes, lips, angles of the nose and mucous membranes. Do not use on cuts, abrasions, eczematous or sunburned skin. As with other retinoids, use of waxing should be avoided on skin treated with adapalene. Patients should use caution with use of DIFFERIN® in combination with products that are potentially irritating, have high concentrations of astringents or alcohol, or contain sulfur, resorcinol, or salicylic acid.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.